Founder of Tianqiao & Chrissy Chen Institute Urges Patience in Brain-Tech Investing

Chen Tianqiao championed the concept of “patient capital” — sustained financial and intellectual support that enables startups to endure the long cycles of fundamental research, product validation, and market adoption. “Capital should empower innovation,” Chen said. “It should not just chase short-term returns.”

TMTPOST -- Billionaire innovator and philanthropist Chen Tianqiao has made a rare public appearance, calling for long-term commitment in brain-computer interface (BCI) investment and warning against applying short-cycle internet-era playbooks to deep tech fields like neuroscience and artificial intelligence.

Chen, founder of Shanda Group and the Tianqiao & Chrissy Chen Institute, praised China’s rapid progress in the BCI sector—particularly in Shanghai—as “truly encouraging,” noting the increasing number of startups, expanding funding rounds, and state-backed initiatives fueling the momentum.

“Four years ago, BrainCo was almost the only invasive BCI startup in China,” Chen said, referencing his early investment in the Shanghai-based company founded by Professor Tao Hu. “Now, the landscape has changed dramatically. Brain-computer interfaces have become a focal point globally, and the sector is attracting leading investors from both state-owned and private capital.”

BrainCo, developed by a team from the Shanghai Institute of Microsystem and Information Technology at the Chinese Academy of Sciences, has since become one of the country’s most recognized players in invasive BCI. The company was named a top enabler of science and technology innovation by the city of Shanghai and is a frequent awardee at the World Artificial Intelligence Conference. Shanda Group is its largest institutional backer.

A Call for "Patient Capital"

Chen’s remarks come as China’s broader science and technology investment community reassesses its strategies in the post-internet era. He cautioned against treating brain-computer interfaces as “just the next money-making trend,” citing Neuralink’s eight-year journey before monetization.

“True technology innovation needs time,” Chen said. “If investors expect quick exits, IPOs, or immediate licensing, they will end up undermining the very breakthroughs they seek.”

Instead, he championed the concept of “patient capital” — sustained financial and intellectual support that enables startups to endure the long cycles of fundamental research, product validation, and market adoption. “Capital should empower innovation,” Chen said. “It should not just chase short-term returns.”

Chen added that Shanda is committed to being such a capital partner, supporting companies like BrainTiger Technology, a BCI startup founded by Tao Hu after leaving his prestigious research post at the Chinese Academy of Sciences. “We are not just investing money. We are building platforms, assembling world-class teams in EEG models, decoding algorithms, and AI systems to give BrainTiger an edge in global competition.”

BrainTiger recently achieved a globally recognized breakthrough in real-time Chinese language and motion decoding, which earned coverage in Nature. Chen called the achievement “as difficult as any Neuralink milestone,” and said the team’s future ambitions include visual reconstruction and memory downloading.

The company’s founding is also becoming a case study in China’s evolving hard-tech ecosystem. According to Chen, many early-stage investors walked away when told the output cycle could exceed 10 years. “I told Tao Hu: even 10 years might not be enough — it could take 20 or 30 — but I am willing to wait.”

Chen praised Hu’s decision to leave academia to fully commit to entrepreneurship. “He is among the very few willing to burn the ships behind him — to give up decades of academic achievement for a chance to change the world through deep tech.”

China’s hard-tech startup boom has recently cooled amid concerns over commercialization delays and founder inexperience. Chen acknowledged the challenges but said the solution lies in building a robust innovation ecosystem.

“Scientists don’t just need funding — they need partners who understand the technology and believe in the mission,” Chen said. “With the right support system, companies like BrainTiger can emerge not only as China’s Neuralink but potentially surpass it.”

As Chen reemerges on the tech stage, his message to investors is clear: Don’t rush. Back bold ideas. And prepare for the long haul.

本文系作者 zhangxinyue 授权钛媒体发表,并经钛媒体编辑,转载请注明出处、作者和本文链接
本内容来源于钛媒体钛度号,文章内容仅供参考、交流、学习,不构成投资建议。
想和千万钛媒体用户分享你的新奇观点和发现,点击这里投稿 。创业或融资寻求报道,点击这里

敬原创,有钛度,得赞赏

赞赏支持
发表评论
0 / 300

根据《网络安全法》实名制要求,请绑定手机号后发表评论

登录后输入评论内容

快报

更多

2026-03-12 23:04

国内商品期市夜盘收盘多数上涨,油脂油料涨幅居前

2026-03-12 22:58

美股存储概念股集体回落,闪迪跌近5%

2026-03-12 22:54

特朗普政府势将暂停实施琼斯法以抑制油价上涨

2026-03-12 22:52

周鸿祎谈“龙虾安全”争议,称“不发展才是最大隐患”

2026-03-12 22:51

RortiX宣布成立低空产业基金,总规模超40亿元

2026-03-12 22:49

欧洲水泥股下挫,欧盟据悉拟放宽碳规则

2026-03-12 22:47

两部门印发示范文本推动合同节水管理健康有序发展

2026-03-12 22:42

费城半导体指数跌超3%

2026-03-12 22:34

美国上周EIA天然气库存减少380亿立方英尺

2026-03-12 22:33

国际油价短线拉升,涨幅扩大至10%

2026-03-12 22:28

美国司法部提起诉讼,旨在阻止加州的电动汽车强制性规定

2026-03-12 22:28

OpenClaw热度持续攀升,“龙虾”硬件设备一机难求

2026-03-12 22:26

谷歌推出人工智能灾害预测方法Groundsource

2026-03-12 22:26

美国新屋开工意外攀升,受多户型住宅项目提振

2026-03-12 22:25

可可期货下跌,产区降雨提振作物预期

2026-03-12 22:20

华峰化学:公司氨纶价格会根据原料价格、市场需求以及市场价格进行调整

2026-03-12 22:19

伊朗新任最高领袖称或开辟新战线

2026-03-12 22:12

Palantir首席执行官:公司产品目前与Anthropic的技术已完成集成

2026-03-12 22:12

王毅同古共中央政治局委员、外交部长罗德里格斯通电话

2026-03-12 22:08

花旗上调伊朗冲突背景下的油价预测

扫描下载App

Baidu
map